Comparing the efficacy and safety of venetoclax combined with hypomethylating agents versus intensive chemotherapy as induction therapy in newly diagnosed core binding factor acute myeloid leukemia patients

被引：0
|
作者：
Shen, Jingyi [1 ,2 ]
Shan, Meng [1 ,2 ]
Chu, Mengqian [1 ,2 ]
Cai, Yiming [1 ,2 ]
Rui, Jingwen [1 ,2 ]
Chen, Suning [1 ,2 ]
Wu, Depei [1 ,2 ]
Xu, Yang [1 ,2 ]
机构：
[1] Soochow Univ, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis, Affiliated Hosp 1, Suzhou, Peoples R China
[2] Soochow Univ, Inst Blood & Marrow Transplantat, Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China
来源：
BLOOD CANCER JOURNAL | 2025年 / 15卷 / 01期
基金：
中国国家自然科学基金;
关键词：
MUTATIONS; CBFB-MYH11; KIT; AML;
D O I：
10.1038/s41408-025-01227-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Compared to Venetoclax Plus Hypomethylating Agents, High Dose Cytarabine Based Intensive Chemotherapy Induction for Newly Diagnosed Acute Myeloid Leukemia (AML) Leads to a Faster Remission Resulting in Better Survival
    Solh, Melhem M.
    Solomon, Scott R.
    Morris, Lawrence
    Holland, H. Kent
    Bachier-Rodriguez, Lizamarie
    Zhang, Xu
    Jackson, Katelin C.
    Bashey, Asad
    BLOOD, 2023, 142
  • [32] DECITABINE COMBINED WITH HAAG AS INDUCTION CHEMOTHERAPY FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
    Tang, X.
    Cui, W.
    Jin, Z.
    Cao, J.
    Guo, D.
    Sun, A.
    Zhu, X.
    Qiu, H.
    Fu, C.
    Han, Y.
    Ruan, C.
    Wu, D.
    HAEMATOLOGICA, 2016, 101 : 383 - 384
  • [33] Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia
    Lim, Matthew J.
    Agha, Aya
    Im, Annie
    Raptis, Anastasios
    Hou, Jing Z.
    Boyiadzis, Michael
    Sehgal, Alison R.
    Redner, Robert L.
    Dorritie, Kathleen
    Marks, Stanley S.
    Agha, Mounzer E.
    Lim, Seah H.
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (02) : 495 - 497
  • [34] Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed acute myeloid leukemia
    DiNardo, Courtney D.
    Lachowiez, Curtis A.
    Takahashi, Koichi
    Loghavi, Sanam
    Kadia, Tapan
    Daver, Naval
    Xiao, Lianchun
    Adeoti, Maria
    Short, Nicholas J.
    Sasaki, Koji
    Wang, Sa A.
    Borthakur, Gautam
    Issa, Ghayas
    Maiti, Abhishek
    Alvarado, Yesid
    Pemmaraju, Naveen
    Bravo, Guillermo Montalban
    Masarova, Lucia
    Yilmaz, Musa
    Jain, Nitin
    Andreeff, Michael
    Garcia-Manero, Guillermo
    Kornblau, Steven
    Ravandi, Farhad
    Jabbour, Elias
    Konopleva, Marina Y.
    Kantarjian, Hagop M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (08) : 1035 - 1043
  • [35] Influence of obesity on efficacy and toxicity of induction chemotherapy in patients with newly diagnosed acute myeloid leukemia
    Lin, Andrew
    Othus, Megan
    McQuary, Amy
    Chi, Mary
    Estey, Elihu
    LEUKEMIA & LYMPHOMA, 2013, 54 (03) : 541 - 546
  • [36] Venetoclax Combined with FLAG-IDA Induction and Consolidation in Newly Diagnosed Acute Myeloid Leukemia
    Lachowiez, Curtis
    DiNardo, Courtney D.
    Takahashi, Koichi
    Loghavi, Sanam
    Xiao, Lian-Chun
    Kadia, Tapan M.
    Daver, Naval
    Adeoti, Maria
    Short, Nicholas J.
    Sasaki, Koji
    Wang, Sa A.
    Borthakur, Gautam
    Issa, Ghayas C.
    Maiti, Abhishek
    Alvarado, Yesid
    Pemmaraju, Naveen
    Montalban-Bravo, Guillermo
    Masarova, Lucia
    Masarova, Lucia
    Jain, Nitin
    Andreeff, Michael
    Garcia-Manero, Guillermo
    Kornblau, Steven M.
    Ravandi, Farhad
    Jabbour, Elias J.
    Konopleva, Marina
    Kantarjian, Hagop
    BLOOD, 2021, 138
  • [37] Venetoclax Combined with FLAG-IDA Induction and Consolidation in Newly Diagnosed Acute Myeloid Leukemia
    Lachowiez, Curtis
    Takahashi, Koichi
    Loghavi, Sanam
    Xiao, Lianchun
    Kadia, Tapan
    Adeoti, Maria
    Short, Nicholas
    Sasaki, Koji
    Wang, Sa
    Borthakur, Gautam
    Issa, Ghayas
    Maiti, Abhishek
    Alvarado, Yesid
    Pemmaraju, Naveen
    Bravo, Guillermo Montalban
    Masarova, Lucia
    Yilmaz, Musa
    Jain, Nitin
    Andreeff, Michael
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Kornblau, Steven
    Ravandi, Farhad
    Konopleva, Marina
    Kantarjian, Hagop
    DiNardo, Courtney
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S291 - S291
  • [38] Venetoclax Combined with Hypomethylation Agents As Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia - Priliminary Results from a Real World Study in China
    Dai, Haiping
    Chen, Jia
    Bao, Xiebing
    Wu, Depei
    Chen, Suning
    BLOOD, 2023, 142
  • [39] Outcomes of Therapy with Venetoclax Combined with Hypomethylating Agents in Favorable-Risk Acute Myeloid Leukemia (AML)
    Arslan, Shukaib
    Zhang, Jianying
    Dhakal, Prajwal
    Moran, Jenna A.
    Naidoo, Nuthana
    Story, Jennifer Lombardi
    Pullarkat, Vinod A.
    Stein, Anthony S.
    Marcucci, Guido
    Yaghmour, George
    Bhatt, Vijaya R.
    Fathi, Amir T.
    Aldoss, Ibrahim
    BLOOD, 2020, 136
  • [40] Economic burden in US patients with newly diagnosed acute myeloid leukemia receiving intensive induction chemotherapy
    Huggar, David
    Knoth, Russell L.
    Copher, Ronda
    Cao, Zhun
    Lipkin, Craig
    McBride, Ali
    LeBlanc, Thomas W.
    FUTURE ONCOLOGY, 2022, 18 (32) : 3609 - 3621
12345